Autopsy report · NCT02023905
Everolimus With and Without Temozolomide in Adult Low Grade Glioma
Cause of deathFunding or business
“Sponsor decision”
Life of this trial
- Registered 3 months before it started.
- Ran for about 7 years 6 months before it stopped.
- 27 participants enrolled.
- Results were posted on the registry 1 year 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of California, San Francisco
- Sponsor type
- University, hospital or other
- Conditions
- Low Grade Glioma; World Health Organization (WHO) Grade II Astrocytomas; Oligodendrogliomas; Mixed Oligoastrocytomas
- Interventions
- Everolimus; Temozolomide
- Participants
- 27
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.